跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ROZLYTREK
Authorized
STANDARD
ROZLYTREK
Hoffmann-La Roche Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bab1d346a133e248
Company
Hoffmann-La Roche Limited
Type
Standard
Approval Details
Approval Id
bab1d346a133e248
Drug Approval Canada Name
ROZLYTREK
Product Name
ROZLYTREK
Status
Marketed
Status Date
2020-03-04
Original Market Date
2020-03-04
Din
02495015
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EX14 ENTRECTINIB
Atc Name
l 01 ex 14
Aig Number
0162010002
Company Name
Hoffmann-La Roche Limited
Company Address
7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8
Active Ingredients
ENTRECTINIB
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bab1d346a133e248
Type
Standard
Back to Health Canada Approvals
ROZLYTREK - Health Canada Drug Approval Details